|
Taipei-based EMO Biomedicine
Corp. was established in 2004, and dedicated to bridge
cell-based bioassay technology and therapeutic HCT/Ps
development for clinical application.
Since 2004, EMO has been
providing comprehensive cell-based bioassays and Contract
Research Services to local and global clients, including
pharmaceutical and biotech companies.
|
|
EMO Biomedicine
offers tailor-made comprehensive research services to satisfy our
clients’ needs
|
